intermediate analogue inhibitors, (13) (14) (15) (16) leading to the identification of α-hydroxybenzylphosphonate (Ki = 4.7 μM(15)), benzohydroxamate (BzH) (Ki = 9.3 μM (15) ), N-hydroxyformanilide (Ki = 2.8 μM(13)), and Cupferron (CfN) (Ki = 2.7 μM(13)) as potent reversible competitive inhibitors of MR. As shown in Figure 1 , both BzH and CfN may be regarded as analogues of the aci-carboxylate intermediate.
Figure 1
Figure 1. Two-base mechanism for MR-catalyzed racemization of (R)-and (S)-mandelate. The molecular electrostatic potential surface (EPS) at the van der Waals radii for the conjugate base of Z-BzH (Odeprotonated (34) ), the putative aci-carboxylate intermediate, and the conjugate base of Z-Cupferron (51) are also shown. EPSs have an electron density isosurface displayed at a density of 0.002 e/ao 3 that encompasses approximately 95% of the van der Waals radii. (52) The energy difference from the red (negative potentials) to blue (more electropositive potentials) regions of the EPSs is 150 kcal/mol, with the more electropositive potential fixed at an upper limit of −50 kcal/mol for all molecules. Geometry optimizations and ESPs were calculated using the density functional B3LYP/6-311+G** method with Spartan'04 Windows version 1.0.1 (Wavefunction, Inc., Irvine, CA).
Herein, we report a critical analysis of TS mimicry by BzH along with the first structures of MR complexed with the intermediate analogues BzH and CfN. The primary determinant of high-affinity binding in MR originates from the coordination of Mg 2+ in the active site. The hydrophobic pocket surrounding the aromatic ring constricts around the intermediate analogues, consistent with the contribution of this region to TS stabilization. In general, however, there appear to be few specific enhanced contacts with analogues of the acicarboxylate intermediate.
Materials and Methods
General (R)-and (S)-Mandelic acid, benzohydroxamate, and all other reagents, unless mentioned otherwise, were purchased from Sigma-Aldrich Canada Ltd. (Oakville, ON). Cupferron (NH4 + salt) was purchased from Fisher Scientific (Ottawa, ON). Circular dichroism (CD) assays and spectral measurements were conducted using a JASCO J-810 spectropolarimeter. DNA oligonucleotide primers were obtained from Integrated DNA Technologies (Coralville, IA, USA) and restriction endonucleases were purchased from New England Biolabs (Ipswich, MA, USA).
Enzyme Purification
For X-ray crystallography studies, recombinant MR from P. putida was overproduced in and purified from Escherichia coli BL21(DE3) cells transformed with the pET-52b(+)-WTMR plasmid, a pET-52b(+) plasmid (Novagen, Madison, WI) containing the MR open reading frame (ORF). (17) This construct encodes the MR gene product (MASWSHPQFEKGALEVLFQGPGYHM1...MR) with an N-terminal StrepII tag (underlined; M1represents the first amino acid of wild-type MR). The enzyme was purified by affinity chromatography using Strep-Tactin Superflow resin (IBA GmbH, Göttingen, Germany) as described previously. (17) Upon elution from the column, the enzyme was dialyzed against storage buffer [HEPES buffer (100 mM, pH 7.5) containing MgCl2 (3.3 mM), NaCl (200 mM), and glycerol (10%, v/v)] and stored at −20 °C. Four or five enzyme preparations were then pooled, dialyzed against HEPES buffer (50 mM, pH 7.5) containing MgCl2 (3.3 mM) and NaCl (50 mM), and concentrated to ∼10 mg/mL using an Amicon Ultracel-10K centrifugal filter unit (Fisher Scientific). The tag was not removed from the enzyme, and the enzyme preparation was immediately frozen as 50 μL aliquots in thinwalled, 250 μL polypropylene microcentrifuge tubes in liquid nitrogen and stored at −80 °C.
Site-Directed Mutagenesis
With the exception of the Y54F and Y54L variants, mutant MRs bearing an N-terminal hexahistidine tag were prepared and purified as described previously. (15, (18) (19) (20) For the Y54F and Y54L MRs, the pET-52b(+)-WTMR plasmid was used as the template for polymerase chain reaction-based site-directed mutagenesis using the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) and following the protocols described by the manufacturer. The forward (F) and reverse (R) synthetic deoxyoligonucleotide primers used to incorporate the desired mutation into the ORFs encoding the Y54F and Y54L MRs are listed in Table S1 of the Supporting Information. After site-directed mutagenesis, mutant plasmids were used to transform competent E. coli DH5α cells for plasmid maintenance. Each mutant ORF was sequenced using commercial automated DNA sequencing (Robarts Research Institute, London, ON) to ensure that no other alterations in the nucleotide sequence had been introduced. E. coli BL21(DE3) cells were used as the host for target gene expression, and the overproduced StrepII-tagged mutant MRs were purified as described previously. (17) Enzyme Assays MR activity was assayed using a CD-based assay by following the change in ellipticity of mandelate at 262 nm with a 1 cm light path (unless otherwise indicated) as described by Sharp et al.(21) All assays were conducted at 25 °C in Na + -HEPES buffer (0.1 M, pH 7.5) containing MgCl2 (3.3 mM, unless mentioned otherwise) and bovine serum albumin (BSA, 0.005%). The concentrations of (R)-and (S)-mandelate for assays of all mutant MR enzymes ranged between 0.25 and 10.0 mM.
Competitive inhibition experiments with BzH were conducted in Na + -HEPES buffer (0.1 M, pH 7.5) containing MgCl2 (3.3 mM, unless mentioned otherwise) and (R)-mandelate (0.5-20.0 mM). Enzyme concentrations and assay details have been described previously. (15, (18) (19) (20) For the inhibition experiments, the following concentrations of the mutant enzyme and BzH were used: 150 ng/mL and 20, 40, and 60 μM, respectively, for the wild-type; 158 ng/mL and 10, 20, 30, and 40 μM, respectively, for Y54F; 321 ng/mL and 25, 50, and 75 μM, respectively, for Y54L (using a cuvette with a 0.5 cm light-path); 300 ng/mL and 200, 400, and 600 μM, respectively, for V22A; 150 ng/mL and 20, 40, and 60 μM, respectively, for V22I; 300 ng/mL and 100, 200, and 400 μM, respectively, for V22F; 450 ng/mL and 100, 200, and 300 μM, respectively, for T24S; 500 ng/mL and 200, 400, and 600 μM, respectively, for A25V; 150 ng/mL and 25, 50, and 75 μM, respectively, for V26A; 450 ng/mL and 200, 400, and 600 μM, respectively, for V26L; 450 ng/mL and 300, 500, and 700 μM, respectively, for V26F; 500 ng/mL and 50, 100, and 200 μM, respectively, for V26A/V29L; 150 ng/mL and 150, 300, and 600 μM, respectively, for V29A; 150 ng/mL and 20, 40, and 80 μM, respectively, for V29L; and 450 ng/mL and 60, 90, and 120 μM, respectively, for V29F. Inhibition constants (Ki) were determined by fitting the initial velocity data to eq 1 using nonlinear regression analysis and KaleidaGraph version 4.02 from Synergy Software (Reading, PA). All kinetic parameters were determined in triplicate, and average values are reported. The reported errors are standard deviations. The concentrations of variant MRs were determined using either the Bio-Rad protein assay (Bio-Rad Laboratories, Mississauga, ON) with BSA standards or from their absorbance at 280 nm using extinction coefficients of 53400 M 
MR with BzH
For the MR crystals grown in the presence of BzH, the reservoir solution consisted of PEG 1500 (14%), glycine (200 mM), NaI (50 mM), and triethanolamine buffer (100 mM, pH 8.0). The protein solution consisted of 6.4 mg/mL MR purified as described above, MgCl2 (3.3 mM), BzH (2 mM), and HEPES buffer (50 mM, pH 7.5). The resulting cubelike crystals (∼65 μm × 65 μm × 40 μm) grew to full size within 5-10 days. After 15 days, the crystals were harvested and transferred to a synthetic stabilizing solution consisting of PEG 1500 (24%), glycine (210 mM), NaI (50 mM), BzH (2 mM), and triethanolamine buffer (80 mM, pH 8.0). These stabilized crystals were transferred in four successive steps to a cryoprotectant solution at ratios of 3:1, 1:1, 1:3, and 0:4 (synthetic:cryoprotectant), with an equilibration time of 5-10 min between transfers. The cryoprotectant consisted of PEG 1500 (38%), glycine (210 mM), NaI (50 mM), BzH (3 mM), and triethanolamine buffer (80 mM, pH 8.0). The cryoprotected crystals were flash-cooled in a nitrogen gas stream at 100 K.
MR with CfN
For the MR crystals grown in the presence of CfN, the reservoir solution consisted of PEG 1500 (20%), glycine (120 mM), NaI (50 mM), and Bis-tris propane buffer (100 mM, pH 9.3). The protein solution consisted of 6.4 mg/mL MR purified as described above, MgCl2 (3.3 mM), CfN (2 mM), and HEPES buffer (50 mM, pH 7.5). The resulting cubelike crystals (∼65 μm × 65 μm × 40 μm) grew to full size within 5-10 days. After 38 days, the crystals were harvested and transferred directly to a cryoprotectant solution consisting of PEG 1500 (44%), glycine (150 mM), CfN (2 mM), and Bis-tris propane buffer (100 mM, pH 9.3), with an equilibration time of 5-10 min. The cryoprotected crystals were flash-cooled in a nitrogen gas stream at 100 K.
Data Collection, Structure Determination, and Refinement X-ray diffraction data were collected at the Advanced Photon Source (APS) beamline LS-CAT-21-ID-F on a Rayonix MarMosaic 225 CCD detector, with an X-ray wavelength of 0.978 Å. Diffraction images were processed using HKL2000.(23) The structures were determined by molecular replacement using the wild-type MR enzyme [Protein Data Bank (PDB) entry 2MNR] as the search model with Phaser. (24) The molecular replacement models were extended by several rounds of manual model building with COOT(25) and refinement with REFMAC(26) using a geometric/X-ray weighting term of 0.2. Noncrystallographic restraints between each monomer were applied for the first round of refinement but were relieved for subsequent rounds. Water molecules were added to the model in COOT with subsequent manual verification. CfN ligand coordinates were generated and optimized for structure refinement using electronic ligand building and optimization workbench (eLBOW). (27) Data collection and processing statistics are summarized in Table 1 . 
Results and Discussion Transition State Mimicry
Hydroxamates have been used as structural mimics of aci-carboxylate intermediates in the characterization of several enolase superfamily enzymes. (28) (29) (30) (31) BzH is a structural and electronic mimic of the aci-carboxylate intermediate and is bound by MR with an affinity that is 100-fold greater than that exhibited for the substrate. (15) The high binding affinity of BzH, however, is not sufficient evidence to classify BzH as a TS analogue. The degree to which an intermediate/TS analogue mimics the structural and electronic character of the true TS can be assessed by comparing the effects of equivalent structural perturbations on the binding affinity of the altered substrate in the TS (via effects on kcat/Km) and on the binding affinity of the putative TS analogue (via effects on Ki). (32, 33) On the basis of eq 2
where knon is the first-order rate constant for reaction in the absence of enzyme and Ktx is the virtual dissociation constant for the enzyme-substrate complex in the TS, a correlation between the free energy change accompanying inhibitor binding (from 1/Ki values) and the relative free energies of activation (from kcat/Km values) for a variety of mutant enzymes catalyzing the same reaction is expected. (32, 33) If a TS analogue inhibitor captures a significant portion of the binding free energy expected for the altered substrate in the TS, then the observed binding affinity, Ki, should approximate Ktx. Table 2 shows the values of Km, kcat, and kcat/Km for wild-type MR and 20 variants along with the competitive inhibition constants for inhibition of these enzymes by BzH. The linear free energy relationship relating the relative free energies of activation for the wild-type and variant enzymes to the corresponding free energies of BzH binding is shown in Figure 2A . While the slope is unity, the correlation is weak (r 2 = 0.74). However, the linear free energy relationship relating the relative free energies of substrate binding (from 1/Km values) to free energies of inhibitor binding ( Figure 2B ) has a slope of only 0.25 and a much weaker correlation (r 2 = 0.14), showing that BzH does indeed exhibit mimicry of the altered substrate in the TS and is not simply acting as a ground state analogue. A detailed analysis of the linear free energy relationship has not been performed for CfN. However, it is isosteric and isoelectronic with BzH ( Figure 1 ) and is bound by the enzyme with high affinity.(13) On this basis, and given that it is bound by MR in a manner analogous to that of BzH (vide infra), CfN may also be regarded as a mimic of the aci-carboxylate intermediate. BzH possesses two sites of deprotonation (i.e., oxygen and nitrogen); therefore, several structures may exist in solution. This is also the case for CfN. In water, BzH exists primarily in the keto form, and experimental evidence suggests that BzH undergoes O-deprotonation in water,(34) yielding a species that does not closely resemble the putative aci-carboxylate intermediate. The pH dependence of BzH inhibition of MR is consistent with the deprotonated form of BzH being preferentially bound by the enzyme. (15) The O-deprotonated enol form of BzH has never been observed in water; however, this form of BzH (cis or trans) more closely resembles the structure of the putative aci-carboxylate intermediate and may therefore be preferentially stabilized within the active site of MR. (15) While BzH and CfN embody certain features of the high-energy intermediate, they are not perfect analogues of the TS for several reasons. First, the electrostatic potential surfaces of BzH and CfN do not perfectly mimic the putative intermediate (Figure 1) . Second, BzH and CfN lack an oxygen that is present in the acicarboxylate intermediate, which does impose a limitation on our structural analysis. Gerlt and Gassman (6) (6, 39) 
General Description of MR Structure
MR is composed of three distinct structural domains: (40) an N-terminal capping domain consisting of a three-stranded β-sheet with an antiparallel four-α-helix bundle, a central domain consisting of a (β/α)7 β-barrel, and a short C-terminal domain composed of external β-strands. As with all TIM-barrel enzymes, the active site is located at the C-terminal ends of the β-strands near the mouth of the barrel. The majority of residues involved in ligand binding, metal ion coordination, and catalysis extend from the β-strands of the barrel. (41) (42) (43) Residues located in the N-terminal capping domain form a hydrophobic cavity that contributes to substrate specificity. This cavity may be partitioned into an R-specific and S-specific pocket (Figure 3) where the phenyl group of (R)-and (S)-mandelate, respectively, is bound upon entering the active site. 1MDR) . The active site has been proposed to include an R-specific pocket and an S-specific pocket, which bind the phenyl group of (R)-and (S)-mandelate, respectively. (19, 46) The S-specific pocket is composed of residues from the 50s loop (colored yellow) and residues 90-95 of a neighboring subunit (colored green). The R-specific pocket is comprised primarily of residues in the 20s loop (colored yellow). The phenyl ring must translocate between the R-and S-specific pockets during catalysis (see Results and Discussion).
The X-ray crystal structures of MR complexed with the intermediate analogues, BzH and CfN, were each determined to 2.2-Å resolution. In both structures, MR is a homo-octamer generated from a tetramer of dimers. Each dimer pair is generated through a tight association between neighboring subunits, with both members of the pair contributing residues to the neighboring active site.(40) Unlike previously reported MR crystal structures, both of the current structures were determined from crystals in space group I4 and included two separate dimers in the asymmetric unit. Each dimer forms an independent octamer through crystallographic symmetry ( Figure S1 of the Supporting Information). The two dimers are nearly identical; the only differences between them are two slight twists in the first and second helices of the (β/α)7 β-barrel ( Figure S2 of the Supporting Information). This small difference between the two octamers is sufficient to render the symmetry noncrystallographic but does not influence the packing of the octamer or the conformation in the individual active sites. Consequently, descriptions of intermediate analogue binding are limited to one representative active site, with all other active sites being identical in their interactions.
Structures of BzH and CfN in the Active Site
The electron density for the BzH and CfN ligands is well-defined over the entire molecule in all four active sites, though the carbon atoms in the aromatic ring of BzH have higher relative temperature factors than the rest of the molecule (Figure 4) . The root-mean-square deviations (rmsds) for structural alignments of the chain A α-carbon atoms of MR bound to (S)-atrolactate (PDB entry 1MDR) with MR bound to BzH and CfN are 0.32 and 0.38 Å, respectively. The rmsds for alignment of the chain A α-carbon atoms of the apo MR structure (PDB entry 2MNR) with the structures of MR bound to BzH and CfN are 0.32 and 0.36 Å, respectively. Hence, there is no crystallographic evidence of large structural changes accompanying the enzyme's transition from the unbound state to the (S)-atrolactate-bound ground state to the intermediate-bound state. There are also no gross differences in the conformation of the 20s or 50s loops between the ground state-bound and intermediate-bound structures ( Figure 5B) . Indeed, comparison of the structures of MR complexed with the ground state analogue (S)-atrolactate with the structures of MR complexed with the intermediate analogues BzH and CfN reveals that the positions of only a few amino acid side chains are altered. Relative to its position in the (S)-atrolactate-bound structure, Lys 166, the S-specific general base catalyst, moves closer to the α-carbon of the planar intermediate analogues ( Figure 5A ). Because MR is a pseudosymmetric enzyme (45) with kcat values in the S → R and R → S directions being approximately equal, one would anticipate that both Lys 166 and His 297 would be in nearly equal proximity to the α-carbon of the aci-carboxylate intermediate and equally poised to protonate it (Figure 1 ). The structure of MR with bound BzH is in agreement with this expectation, and this is the first structure of liganded MR in which the ζ-and ε 2+ removed and the contribution to the active site from the dimerization interface included. In all cases, the cavity search was initiated at the equivalent of the β-carbon position of (S)-atrolactate in chain A, after all PDB files had been structurally overlaid for chain A. The calculated protein surface lining the 1MDR cavity (over a 14 Å × 14 Å × 12 Å grid map) is displayed as a partially translucent white isosurface. The yellow mesh illustrates the active site cavity in 1MDR, the green mesh that in the MR-CfN complex, and the pink mesh that in the MR-BzH complex. (S)-Atrolactate is illustrated as yellow sticks. All residues lining the cavity are shown and labeled. Leu 93′ from the neighboring chain can be seen behind (S)-atrolactate and, for the sake of clarity, is not labeled.
Hydrophobic effects contribute to TS stabilization by MR,(46) suggesting a possible role for hydrophobic cavity residues in specifically stabilizing the altered substrate in the TS. However, no major changes in the positions of hydrophobic amino acid side chains located in the hydrophobic cavity can be confidently identified in the structures of MR with either bound CfN or BzH at 2.2-Å resolution. That said, Tyr 54, which is part of the 50s loop of the S-specific pocket,(19) does appear to change its orientation slightly in the intermediate-bound state, moving closer to the phenyl ring of BzH and CfN, thereby raising the possibility that it may interact with the phenyl ring of the aci-carboxylate intermediate during catalysis (Figure 5B ). To assess whether Tyr 54 plays a specific role in TS stabilization by MR, the Y54F and Y54L mutants were generated and the impact of these mutations on the interconversion of (R)-and (S)-mandelate was determined. Relative to those of wild-type MR, the Y54F mutation had negligible effects on the values of Km, kcat, and kcat/Km when either (R)-or (S)-mandelate was the substrate, and the binding affinity of BzH was not altered significantly for this mutant (Table 2) . Hence, interactions with the hydroxyl group of Tyr 54 do not play a significant role in TS stabilization. If the aromatic ring of Tyr 54 plays a specific role in TS stabilization, then the Y54L mutation should exhibit a much more significant effect on kcat/Km than on Km for (R)-and (S)-mandelate. Conversely, if Tyr 54 contributes generally to the packing of the hydrophobic cavity, the Y54L mutation is expected to have an effect on both substrate binding [manifested in Km for (R)-and (S)-mandelate, because Km = Ks for MR(3)] and TS stabilization (manifested in kcat/Km). The Y54L mutation results in an ∼2-fold increase in Kmover that of the wild-type enzyme and a 3.5-fold decrease in kcat/Km when either (R)-or (S)-mandelate is the substrate (Table 2) . Interestingly, the effect of the Y54L mutation on the steady state kinetic parameters is much smaller than the effect observed upon mutation of several other hydrophobic pocket residues (Table 2) . Thus, the motion of the Tyr 54 side chain is likely a consequence of altered packing rearrangements in the hydrophobic pocket rather than a result of a specific role for Tyr 54 in TS stabilization. Nevertheless, the movement of Tyr 54 combined with a modest movement of other hydrophobic cavity side chains such as Phe 52 ( Figure 5B) suggests that the entire hydrophobic cavity may contract around the planar intermediate. Indeed, estimation of the size of the hydrophobic cavity using VOIDOO (http://xray.bmc.uu.se/usf/voidoo.html) (47) Figure 6 ). Superposition of the structures of MR complexed with BzH, CfN, and (S)-atrolactate reveals that, while the enzyme residues responsible for chelating Mg 2+ do not undergo changes in their position or orientation, the distances between the chelating oxygen atoms of these compounds and the Mg 2+ ion do vary. The distances between the Mg 2+ and the chelating oxygen atoms of the carboxylate and hydroxyl groups of (S)-atrolactate are 2.2 and 2.3 Å, respectively, and the corresponding distances in the BzH and CfN complexes are 2.2 and 2.1 Å, respectively, and 2.0 and 2.1 Å, respectively. The decreased distances between the chelating oxygens of BzH and CfN and the Mg 2+ ion suggest that the interaction with the Mg 2+ ion is stronger than that in the ground state structure. Thus, some portion of the enhanced binding affinity observed for both BzH and CfN may result from their higher relative affinity for Mg 2+ as compared to those of ground state ligands. (35, 48) Although the enhanced binding of BzH and CfN, relative to that observed for the ground state analogue (S)-atrolactate (Ki = 0.15 mM (42) 
Substrate Motion during Catalysis
Analysis of site-directed mutagenesis studies (19) and competitive inhibition of MR by benzilate(46) led us to propose that the phenyl ring of mandelate traverses the hydrophobic cavity as the enzyme interconverts (R)-and (S)-mandelate. However, the magnitude of the motion remains unknown. Two scenarios have been envisioned for this phenyl motion ( Figure 7A ). (19) In one scenario, the β-carbon (C1 of the phenyl ring) remains stationary throughout the reaction, maintaining a plane with the carboxylate and hydroxyl groups. In this scenario, the α-carbon moves by ∼1.0 Å as it undergoes Walden inversion and the paracarbon of the phenyl ring moves by ∼1.8 Å. Alternatively, in the second scenario, the α-carbon remains fixed throughout catalysis, resulting in a greater compensatory movement of the phenyl ring (∼2.8 Å at the para carbon) as it pivots about the α-carbon. The crystal structures of MR with BzH and CfN offer some insight into distinguishing between these two scenarios and suggest that the α-carbon moves and the position of the β-carbon remains roughly fixed. Structural overlays of MR with the bound intermediate analogues compared with bound (S)-atrolactate ( Figure 7B ) reveal that (i) the α-carbon moves 0.7-0.8 Å from the position it occupies in (S)-atrolactate to the position it occupies in the planar intermediate analogues, (ii) the β-carbon remains fixed in a nearly identical position, and (iii) the para carbon of the aromatic ring moves between 0.8 and 1.2 Å. Consequently, the observed movement of the para carbon suggests that the total distance traversed through the hydrophobic cavity by the para carbon of the phenyl ring upon interconversion of (S)-and (R)-mandelate is on the order of 1.6-2.4 Å, reduced slightly from the value of 2.8 Å (Figure 7A ) by the compensating movement of the α-carbon during catalysis. Of course, a smaller range of substrate motion in the hydrophobic pocket requires fewer rearrangements of the hydrophobic cavity during catalysis. MR, like all members of the enolase superfamily MR subgroup, orients the substrate such that it coordinates the essential Mg 2+ using one carboxylate oxygen and the α-OH group. (49) In all enolase superfamily enzymes, the α-carbon undergoes a transition from sp 3 to sp 2 hybridization as the reaction progresses from the substrate to the enolate intermediate, and the resulting structural rearrangements in the substrate have, in some instances, been proposed to play a direct role in the catalytic mechanism. For example, l-rhamnonate dehydratase, a member of the MR subgroup, has a single general acid/base residue in the active site. The transition from sp 3 to sp 2 hybridization of the α-carbon in the enolate intermediate is proposed to facilitate movement of the β-carbon, permitting His 329 to function both as the general base to deprotonate the α-carbon and as the general acid to facilitate departure of the β-OH group in the syn dehydration reaction. (50) The structures of MR with bound intermediate analogues suggest that, for members of the MR subgroup, which orient the substrate to coordinate Mg 2+ with the α-OH group, the β-carbon is not likely to undergo significant movement as the reaction proceeds from the ground state to the intermediate state. Rather, the general acid/base catalyst itself may move closer to the intermediate. Just such a movement is observed for Lys 166 in MR when the structure of MR with bound (S)-atrolactate is compared with the structures of MR with bound intermediate analogues ( Figure 5A ), bearing in mind the caveat outlined above concerning the steric effect of the α-CH3 group of (S)-atrolactate. Structures of l-talarate/galactarate dehydratase, another member of the enolase superfamily MR subgroup, complexed both with a hydroxamate intermediate analogue and with the substrate also reveal greater movement of the α-carbon than the β-carbon.(31) However, it is important to note that the introduction of a mutation into the general base, K197A, makes it difficult to directly compare the relative movement of these atoms in the structures because the entire ligand shifts in the direction of the void created by the K197A mutation in the l-talarate/galactarate dehydratase structure.
Conclusions
The crystal structures of MR with the bound intermediate analogues BzH and CfN reveal several structural features that had not been evident in the previously reported structures of MR with bound ground state analogues. (40) (41) (42) (43) (44) These are the first structures of MR bearing a ligand in which the general acid/base catalysts, Lys 166 and His 297, are located equidistant from the α-carbon of the ligand. The distance between the chelating oxygen atoms of the intermediate analogues and the Mg 2+ becomes slightly shorter, relative to the corresponding distances in the ground state structure, suggesting that both BzH and CfN form a tighter complex with the catalytic Mg 2+ as would also be expected for the aci-carboxylate intermediate. Tyr 54 moves closer to the phenyl ring of the bound intermediate analogues, and there is a concomitant constriction of the hydrophobic cavity within the active site. Finally, the para carbon of the phenyl ring of the substrate pivots about the β-carbon by 0.8-1.2 Å between the ground state and intermediate state, consistent with the proposal that the phenyl ring moves during MR catalysis while the polar groups remain relatively fixed. The overall protein architecture of the active site of MR with either BzH or CfN bound is very similar to that of MR with (S)-atrolactate bound, suggesting that the alterations in enzyme structure contributing to discrimination between the altered substrate in the TS and the ground state by this proficient enzyme are extremely subtle. 
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